Rousseau, M.C., M.E. Parent, L. Nadon, B. Latreille, and J. Siemiatycki. 2007. Occupational exposure to lead compounds and risk of cancer among men: A population-based case-control study. Am. J. Epidemiol. 166(9):1005-1014.
Schober, S.E., L.B. Mirel, B.I. Graubard, D.J. Brody, and K.M. Flegal. 2006. Blood lead levels and death from all causes, cardiovascular disease, and cancer: Results from the NHANES III mortality study. Environ. Health Perspect. 114(10):1538-1541.
Shimkin, M.B., G.D. Stoner, and J.C. Theiss. 1977. Lung tumor response in mice to metals and metal salts. Adv. Exp. Med. Biol. 91:85-91.
Southard, E.B., A. Roff, T. Fortugno, J.P. Richie, Jr., M. Kaag, V.M. Chinchilli, J. Virtamo, D. Albanes, S. Weinstein, and R.T. Wilson. 2012. Lead, calcium uptake, and related genetic variants in association with renal cell carcinoma risk in a cohort of male Finnish smokers. Cancer Epidemiol. Biomarkers Prev. 21(1):191-201.
Steenland, K., and P. Boffetta. 2000. Lead and cancer in humans: Where are we now? Am. J. Ind. Med. 38(3):295-299.
Stoner, G.D., M.B. Shimkin, M.C. Troxell, T.L. Thompson, and L.S. Terry. 1976. Test for carcinogenicity of metallic compounds by the pulmonary tumor response in strain A mice. Cancer Res. 36(5):1744-1747.
van Bemmel, D.M., P. Boffetta, L.M. Liao, S.I. Berndt, I. Menashe, M. Yeager, S. Chanock, S. Karami, D. Zaridze, V. Matteev, V. Janout, H. Kollarova, V. Bencko, M. Navratilova, N. Szeszenia-Dabrowska, D. Mates, A. Slamova, N. Rothman, S.S. Han, P.S. Rosenberg, P. Brennan, W.H. Chow, and L.E. Moore. 2011. Comprehensive analysis of 5-aminolevulinic acid dehydrogenase (ALAD) variants and renal cell carcinoma risk among individuals exposed to lead. PLoS One. 6(7):e20432.
van Esch, E.J., and R. Kroes. 1969. The induction of renal tumors by feeding basic lead acetate to mice and hamsters. Br. J. Cancer 23(4):765-771.
van Esch, G.J., G. Van Genderen, and H.H. Vink. 1962. The induction of renal tumors by feeding of basic lead acetate to rats. Br. J. Cancer 16(2):289-297.
van Wijngaarden, E., and F. Dosemeci. 2006. Brain cancer mortality and potential occupational exposure to lead: Findings from the National Longitudinal Mortality Study, 1978-1989. Int. J. Cancer 119(5):1136-1144.
Waalkes, M.P., B.A. Diwan, J.M. Ward, D.E. Devor, and R.A. Goyer. 1995. Renal tubular tumors and atypical hyperplasias in B6C3F1 mice exposed to lead acetate during gestation and lactation occur with minimal chronic nephropathy. Cancer Res. 55(22):5265-5271.
Ward, E.M., P.A. Schulte, K. Straif, N.B. Hopf, J.C. Caldwell, T. Carreón, D.M. De-Marini, B.A. Fowler, B.D. Goldstein, K. Hemminki, C.J. Hines, K.H. Pursiainen, E. Kuempel, J. Lewtas, R.M. Lunn, e. Lynge, D.M. McElvenny, H. Muhle, T. Nakajima, L.W. Robertson, N. Rothman, A.M. Ruder, M.K. Schubauer-Berigan, J. Siemiatycki, D. Silverman, M.T. Smith, T. Sorahan, K. Steenland, R.G. Stevens, P. Vineis, S.H. Zahm, L. Zeise, and V.J. Cogliano. 2010. Research recommendations for selected IARC-classified agents. Environ. Health Perspect. 118(10):1355-1362.
Waszynski, E. 1977. Nonneoplastic and neoplastic changes in the kidneys and other organs in rodents fed lead acetate and sulfathiazole chronically. Pathol. Pol. 28:101-111.